6-Hydroxy-DOPA结构式
|
常用名 | 6-Hydroxy-DOPA | 英文名 | 6-Hydroxy-DL-DOPA |
|---|---|---|---|---|
| CAS号 | 21373-30-8 | 分子量 | 213.18700 | |
| 密度 | 1.606g/cm3 | 沸点 | 515.2ºC at 760mmHg | |
| 分子式 | C9H11NO5 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 265.4ºC |
6-Hydroxy-DOPA用途6-羟基多巴是RAD52单链DNA结合域选择性和有效的变构抑制剂。6-羟基多巴可用于癌症研究[1]。 |
| 中文名 | 6-羟基-DL-DOPA |
|---|---|
| 英文名 | 6-hydroxydopa |
| 英文别名 | 更多 |
| 描述 | 6-羟基多巴是RAD52单链DNA结合域选择性和有效的变构抑制剂。6-羟基多巴可用于癌症研究[1]。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
RAD52[1] |
| 体外研究 | 6-羟基多巴(0~20μM;U20S细胞)选择性抑制RAD52介导的重组。6-羟基多巴(0~10μM;HEK293T细胞)以剂量依赖性方式减少eGFP-RAD52病灶的数量。6-羟基多巴(5~75μM;HCC1937细胞)选择性降低BRCA1缺陷型三阴性乳腺癌细胞系HCC1937的生存能力[1]。 |
| 参考文献 |
| 密度 | 1.606g/cm3 |
|---|---|
| 沸点 | 515.2ºC at 760mmHg |
| 分子式 | C9H11NO5 |
| 分子量 | 213.18700 |
| 闪点 | 265.4ºC |
| 精确质量 | 213.06400 |
| PSA | 124.01000 |
| LogP | 0.45810 |
| InChIKey | YLKRUSPZOTYMAT-UHFFFAOYSA-N |
| SMILES | NC(Cc1cc(O)c(O)cc1O)C(=O)O |
| 储存条件 | 2-8°C,密封,干燥 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | 22-24/25 |
| 危险品运输编码 | NONH for all modes of transport |
|
The free radical site in pea seedling copper amine oxidase probed by resonance Raman spectroscopy and generated by photolysis of caged substrate.
FEBS Lett. 380(1-2) , 183-7, (1996) Resonance Raman spectra were obtained of the free radical site in substrate reduced anaerobic samples of pea seedling copper amine oxidase (PSAO). The spectra differ significantly from those reported ... |
|
|
Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Synapse 61 , 606-614, (2007) Evidence obtained in rodent and primate models of Parkinson's disease (PD) and preliminary clinical trials, indicates that adenosine A(2A) receptor antagonists might represent a promising nondopaminer... |
|
|
Up-regulation in expression of vesicular glutamate transporter 3 in substantia nigra but not in striatum of 6-hydroxydopamine-lesioned rats.
Neurosignals 15(5) , 238-48, (2006) Overactivity of the glutamatergic system is suggested to be closely related to the onset and pathogenesis of Parkinson's disease. Vesicular glutamate transporters (VGLUT1, T2 and T3) are a group of gl... |
| 2,5-Dihydroxytyrosine |